Loading...
XSHE
300765
Market cap7.95bUSD
May 20, Last price  
46.45CNY
1D
10.33%
1Q
72.23%
IPO
488.89%
Name

CSPC Innovation Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:300765 chart
P/E
1,067.80
P/S
28.96
EPS
0.04
Div Yield, %
0.83%
Shrs. gr., 5y
7.28%
Rev. gr., 5y
9.53%
Revenues
1.98b
-20.82%
650,715,959742,010,176890,477,1971,031,180,9651,240,098,6911,256,502,3591,317,414,1221,431,987,6642,626,488,8322,501,699,9051,980,753,001
Net income
54m
-92.89%
108,235,384115,590,425206,576,912194,911,146223,840,143273,197,126299,835,756393,228,489726,277,891755,557,25353,726,318
CFO
0k
-100.00%
93,362,300112,048,300137,266,7311,300,210159,727,619315,384,186349,071,664170,592,336640,717,518927,241,2260
Dividend
Apr 25, 20240.384 CNY/sh

Profile

CSPC Innovation Pharmaceutical Co., Ltd. manufactures and sells caffeine, and vitamin C health supplement and beverage products. The company is based in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC Pharmaceutical Group Limited.
URL
http://www.xnwpharma.net/
IPO date
Mar 22, 2019
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,980,753
-20.82%
2,501,700
-4.75%
2,626,489
83.42%
Cost of revenue
2,133,634
1,600,847
1,800,301
Unusual Expense (Income)
NOPBT
(152,881)
900,853
826,188
NOPBT Margin
36.01%
31.46%
Operating Taxes
81,912
136,470
124,761
Tax Rate
15.15%
15.10%
NOPAT
(234,793)
764,383
701,427
Net income
53,726
-92.89%
755,557
4.03%
726,278
84.70%
Dividends
(97,848)
(97,562)
Dividend yield
0.23%
1.00%
Proceeds from repurchase of equity
483,919
(69)
BB yield
-1.13%
0.00%
Debt
Debt current
223
Long-term debt
1,682
19,800
Deferred revenue
90,487
33,258
37,208
Other long-term liabilities
1
1
Net debt
(1,136,530)
(3,420,490)
(2,429,151)
Cash flow
Cash from operating activities
927,241
640,718
CAPEX
(95,732)
Cash from investing activities
(92,986)
311,878
Cash from financing activities
365,206
FCF
(1,535,621)
819,801
272,266
Balance
Cash
1,342,172
3,422,173
2,195,684
Long term investments
(205,642)
253,489
Excess cash
1,037,492
3,297,088
2,317,849
Stockholders' equity
3,497,976
4,017,460
2,806,623
Invested Capital
3,548,925
1,824,174
1,644,127
ROIC
44.08%
46.04%
ROCE
17.59%
20.85%
EV
Common stock shares outstanding
1,396,512
1,170,522
1,114,067
Price
26.59
-27.39%
36.62
317.72%
8.77
2.87%
Market cap
37,133,258
-13.37%
42,864,510
338.89%
9,766,655
16.61%
EV
36,762,114
39,452,374
7,346,098
EBITDA
64,448
1,000,950
899,132
EV/EBITDA
570.42
39.41
8.17
Interest
6,373
640
219
Interest/NOPBT
0.07%
0.03%